Literature DB >> 16872712

Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome.

K M Choi1, O H Ryu, K W Lee, H Y Kim, J A Seo, S G Kim, N H Kim, D S Choi, S H Baik.   

Abstract

We examined the association between interleukin-10 (IL-10), adiponectin levels and inflammatory markers such as interleukin-6 (IL-6) and high-sensitive C-reactive protein (hsCRP). Furthermore, the association of these anti-/pro-inflammatory cytokine levels with the metabolic syndrome was investigated. The study subjects were composed of 312 Korean individuals without diabetes. Serum adiponectin level was associated with hsCRP (r=-0.21, P<0.001), IL-6 (r=-0.13, P<0.05) and IL-10 (r=-0.22, P<0.001) levels. Subjects without the metabolic syndrome showed higher adiponectin (17.03 microg/ml versus 13.85 microg/ml, P<0.001) and IL-10 (4.74 pg/ml versus 4.34 pg/ml, P=0.014) levels, and lower serum hsCRP (0.38 microg/ml versus 0.66 microg/ml, P=0.001) and IL-6 (0.94 pg/ml versus 1.32 pg/ml, P=0.009) levels compared to those with the metabolic syndrome. In multiple logistic regression analysis, the metabolic syndrome was associated with sex, age, waist circumference, systolic blood pressure, HDL cholesterol, triglyceride, fasting blood glucose and interleukin-10. Furthermore, serum adiponectin levels are associated with serum hsCRP, IL-6 and IL-10 levels. These results suggest that adiponectin might be associated with the metabolic syndrome through regulation of pro-/anti-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872712     DOI: 10.1016/j.diabres.2006.06.019

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  35 in total

1.  Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study.

Authors:  Luisa Costa; Francesco Caso; Roberta Ramonda; Antonio Del Puente; Luca Cantarini; Md Abud Darda; Paolo Caso; Mariagrazia Lorenzin; Ugo Fiocco; Leonardo Punzi; Raffaele Scarpa
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Obesity in cancer survival.

Authors:  Niyati Parekh; Urmila Chandran; Elisa V Bandera
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

Review 3.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

4.  Brief Report: Circulating Markers of Immunologic Activity Reflect Adiposity in Persons With HIV on Antiretroviral Therapy.

Authors:  John R Koethe; Cathy A Jenkins; Briana D Furch; Jordan E Lake; Louise Barnett; Cindy C Hager; Rita Smith; Todd Hulgan; Bryan E Shepherd; Spyros A Kalams
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

5.  Obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors.

Authors:  Niyati Parekh; Tomoko Okada; Grace L Lu-Yao
Journal:  J Am Diet Assoc       Date:  2009-08

6.  Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease.

Authors:  Hongmei Zhang; Yixin Niu; Hongxia Gu; Shuai Lu; Weiwei Zhang; Xiaoyong Li; Zhen Yang; Li Qin; Qing Su
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

7.  A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors.

Authors:  Maria Sole Chimenti; Paola Triggianese; Paola Conigliaro; Marco Tonelli; Gianfranco Gigliucci; Lucia Novelli; Miriam Teoli; Roberto Perricone
Journal:  Clin Rheumatol       Date:  2017-07-31       Impact factor: 2.980

8.  Association of IL-10 gene (-1082A>G, -819C>T and -592C>A) polymorphism and its serum level with metabolic syndrome of north Indian subjects.

Authors:  Amit Kumar Madeshiya; Shraddha Singh; Shipra Dwivedi; Rituraj Konwar; Shankar Madhav Natu; Ashim Ghatak
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

9.  Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients.

Authors:  Luisa Costa; Francesco Caso; Mariangela Atteno; Antonio Del Puente; Md Abud Darda; Paolo Caso; Augusta Ortolan; Ugo Fiocco; Roberta Ramonda; Leonardo Punzi; Raffaele Scarpa
Journal:  Clin Rheumatol       Date:  2014-06       Impact factor: 2.980

10.  Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey.

Authors:  Niyati Parekh; Yong Lin; Richard B Hayes; Jeanine B Albu; Grace L Lu-Yao
Journal:  Cancer Causes Control       Date:  2010-01-23       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.